CA2199756A1 - Mobilisation de cellules utilisant un traitement in vivo avec l'hyaluronan (ha) - Google Patents

Mobilisation de cellules utilisant un traitement in vivo avec l'hyaluronan (ha)

Info

Publication number
CA2199756A1
CA2199756A1 CA002199756A CA2199756A CA2199756A1 CA 2199756 A1 CA2199756 A1 CA 2199756A1 CA 002199756 A CA002199756 A CA 002199756A CA 2199756 A CA2199756 A CA 2199756A CA 2199756 A1 CA2199756 A1 CA 2199756A1
Authority
CA
Canada
Prior art keywords
hyaluronic acid
cells
daltons
molecular weight
acceptable salts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002199756A
Other languages
English (en)
Inventor
Linda May Pilarski
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hyal Pharmaceutical Corp
Original Assignee
Hyal Pharmaceutical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hyal Pharmaceutical Corp filed Critical Hyal Pharmaceutical Corp
Priority to CA002199756A priority Critical patent/CA2199756A1/fr
Publication of CA2199756A1 publication Critical patent/CA2199756A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA002199756A 1996-03-14 1997-03-12 Mobilisation de cellules utilisant un traitement in vivo avec l'hyaluronan (ha) Abandoned CA2199756A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA002199756A CA2199756A1 (fr) 1996-03-14 1997-03-12 Mobilisation de cellules utilisant un traitement in vivo avec l'hyaluronan (ha)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US60/013,401 1996-03-14
CA002199756A CA2199756A1 (fr) 1996-03-14 1997-03-12 Mobilisation de cellules utilisant un traitement in vivo avec l'hyaluronan (ha)

Publications (1)

Publication Number Publication Date
CA2199756A1 true CA2199756A1 (fr) 1998-09-12

Family

ID=4160153

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002199756A Abandoned CA2199756A1 (fr) 1996-03-14 1997-03-12 Mobilisation de cellules utilisant un traitement in vivo avec l'hyaluronan (ha)

Country Status (1)

Country Link
CA (1) CA2199756A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006072243A1 (fr) * 2005-01-03 2006-07-13 Novozymes Biopolymer A/S Fraction acide hyaluronique ayant des proprietes hydratantes et antirides

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006072243A1 (fr) * 2005-01-03 2006-07-13 Novozymes Biopolymer A/S Fraction acide hyaluronique ayant des proprietes hydratantes et antirides

Similar Documents

Publication Publication Date Title
US20090029941A1 (en) Methods for cell mobilization using in vivo treatment with hyaluronan (ha)
AU2004242091B2 (en) Administration of hyaluronic acid to enhance the function of transplanted stem cells
Cecil et al. Outer membrane vesicles prime and activate macrophage inflammasomes and cytokine secretion in vitro and in vivo
Sun et al. CD39/ENTPD1 expression by CD4+ Foxp3+ regulatory T cells promotes hepatic metastatic tumor growth in mice
Bar-Yehuda et al. Resistance of muscle to tumor metastases: a role for a3 adenosine receptor agonists
JP2613605B2 (ja) 抗菌物質として有効なヒアルロン酸の重金属塩
Currier et al. Effect over time of in-vivo administration of the polysaccharide arabinogalactan on immune and hemopoietic cell lineages in murine spleen and bone marrow
JP5662309B2 (ja) 腫瘍性疾患を治療するための組成物および方法
Irintchev et al. Cellular and molecular reactions in mouse muscles after myoblast implantation
CN114306615B (zh) 脆弱拟杆菌荚膜多糖a与免疫检查点抑制剂的新应用
EP0914133B1 (fr) Utilisation de l'hyaluronane (ha) pour la mobilisation cellulaire
US20050113335A1 (en) Methods for cell mobilization using in vivo treatment with hyaluronan (HA)
JP3150967B2 (ja) 二本鎖ｒｎａによる損傷に続くショックからの保護
Halaas et al. Mannuronan enhances survival of lethally irradiated mice and stimulates murine haematopoiesis in vitro
CA2199756A1 (fr) Mobilisation de cellules utilisant un traitement in vivo avec l'hyaluronan (ha)
Wong et al. In vivo proliferation of adoptively transferred tumor-infiltrating lymphocytes in mice
EP1613340B1 (fr) Traitement d'infections par i aspergillus /i a l'aide de thymosine alpha 1
Papamatheakis et al. Cell and Tissue Distribution of ¹¹C-Labeled Pyran Copolymer
US20230059785A1 (en) Methods for enhancing t cells using venetoclax
Kelsey et al. Functional significance of induction of differentiation in human myeloid leukaemic blasts by 1, 25-dihydroxyvitamin D3 and GM-CSF
Tuttle et al. Adoptive transfer of bryostatin 1-activated T cells provides long-term protection from tumour metastases
Vincent-Naulleau et al. Stimulatory effects of polar glycopeptidolipids of Mycobacterium chelonae on murine haematopoietic stem cells and megakaryocyte progenitors
CA2173272C (fr) Stimulation de cellules souches et d'autres cellules
FR2691066A1 (fr) Utilisation de glycosaminoglycanes exogènes, de leurs analogues ainsi que de leurs fragments, fractions et dérivés, pour la préparation de médicaments destinés au traitement de thrombopénies.
Vanclée et al. Murine dendritic cells that are resistant to maturation are unable to induce tolerance to allogeneic stem cells

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead